Dear visitor, dear colleague
Welcome to the website of RAMSES.
RAMSES is a project of the Seventh Framework Programme (FP7) of the European Commission.
The concept of RAMSES is to build capacities in a Mediterranean partner country and within the European Research Area by improving scientific relationships, networking and development of the science and technology human potential, exchanging of know-how and experience between the participating partners, as well as by upgrading research capacities together with close bench and bedside co-operation of the Mediterranean Partner Country research entity in the field of understanding stem cell physiology and possible future therapeutic impact.
This shall provide our Mediterranean partner in Egypt the opportunity to develop a partnership through twinning actions with centres of excellence in Germany and Romania.
Based on the already gained expertise in the field of stem cell research, the Egyptian, Romanian and German groups have proposed to further join their efforts to advance the international stem cell research field to clinical applications for cardiovascular diseases.
Herein, we aim to provide a wealth of useful information concerning the involved partners and our activities.
For further information concerning specific topics, please use the navigation links on the top of this page.
There are already intense cooperation efforts between the University of Cologne and the Institute of Cellular Biology and Pathology “Nicolae Simionescu”, Bucharest (since 2008) regarding adult stem cell research, particularly in the cardiovascular field. In Cologne as well as in Bucharest, the establishment of an intense linkage between clinical and basic research has been very successful to virtually enable “bench to bedside” research programs. In addition, there is already a very fruitful cooperation (since 2006) between the Department of Pediatric Cardiology of the University of Cologne and the Department of Pediatric Cardiology of Cairo University (CU), the biggest and oldest university in Egypt.
Because ethical and immunological concerns are associated with human embryonic stem cells derived from the inner cell mass of blastocysts, the consortium will not consider human embryonic stem cells in his project.